sign in sign up
<<
Home , ART4, Basigin, BMPR1B, CD137, CD155, CD160

CD CHART

CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells / Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 product, E2 p p p CD223 LAG-3 ( activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (g-glutamyl ) p p p p p p CD1c , M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, induced transmembrane 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red (SRBC) ; LFA-2 p S n p n n l CD103 HML-1 (human mucosal 1), aE chain S n n n n n n n l CD228 (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n n n p p CD3d CD3δ p CD105 n n n n S n n p p l CD230 Prion protein, PrPc p p p p p p p p p CD3e CD3ε p CD106 VCAM-1 (vascular molecule-1), INCAM-110 n n n n S n n Folli Act l CD231 TALLA-1, TM4SF2, A15, MXS1, CCG- CD3g CD3γ p CD107a LAMP-1 Act Act Act Act Act Act n l CD232 VESP R, PLXNC1, plexin C1 p p p p p CD4 T4 S n p n p n n n n n l CD107b LAMP-2 Act Act Act Act Act Act n CD233 band 3, SLC4A1, AE1, Diego blood group, EPB3 n n n n n p n CD5 T1, Tp67 p S / Low n n n n n l CD108 JMH human blood group antigen, Sema L, GPI-gp80 Low Low n n p CD234 Fy-, Duffy blood group antigen, DARC n n n n n p n p p CD6 T12, Tp120 p S n n n n l CD109 8A3, E123, activation factor Act n n n n Act n S p S l CD235a A, PAS-2 n n n n n p p n l CD7 gp40, Tp41 S n n S n n n p l CD110 TPO-R ( receptor), c-mlp n n n n n p n p n p p CD235b Glycophorin B, PAS-3 p CD8 T8, LeuT S n n S n n n n n n l CD111 PRR1, nectin1, Hve C1, PVRL1 n n S p p p S p p CD236 /D p CD8b - S n n n n n n n n n l CD112 PRR2, nectin2, Hve B, PVRL2 n S p p n S p p CD236R Glycophorin C p CD9 p24, MRP-1, MIC3, Tspan-29 Act Act Low p p n p p l CD113 PRR3 , 3, PVRL3 p CD238 Kell blood group antigen p CD10 CALLA, neutral endopeptidase (NEP), gp100 n n p n n n n p l CD114 G-CSFR, HG-CSFR, CSF3R n n p n p p n p p CD239 B-CAM, Lutheran glycoprotein p p p CD11a aL integrin chain; LFA-1, gp180/95 p p Low p p n n l CD115 M-CSFR, CSF-1R, c-fms n n n p n n p n CD240 , Rh30CE p p CD11b aM integrin chain, Mac-1, Mo1, CR3, a-chain of C3biR S S p p p n Folli n l CD116 GM-CSF receptor a-subunit n n p n p n n p l CD241 RhAG, Rh50 n n n n n n p n n CD11c aX integrin chain, p150,95, CR4 S / Low S / Low Low p p n p n l CD117 c-, receptor (SCFR) n n n n n n n p n n l CD242 ICAM-4, LW blood group n n n n n n p p n CD11d integrin aD subunit p CD118 LIFR ( inhibitory factor receptor) p CD243 MDR-1 (multidrug resistance protein I), Pgp (P-glycoprotein) n n n n n n n p p p l CDw12 p90-120 n n p p p p n p CD119 IFNg receptor a-chain, IFNgRI p p p p p n p CD244 2B4, NAIL, p38 S n S p p l CD13 Aminopeptidase N, APN, (EC 3.4.11.2), gp150, ANPEP p n p n p n n p p p l CD120a TNF receptor type 1, TNFR p55 p p p p p n p p p l CD245 p220/240 S / Low p p p p CD14 LPS receptor n Low Low n p l CD120b TNF receptor type 2, TNFR p75 p p p p p n p p p l CD246 ALK (anaplastic lymphoma ) CD15 Lewis X (Le-X), 3-fucosyl-N-acetyl-lactosamine ( 3-FAL) S / Act S / Act p n p n n p S / Act n S l CD121a IL-1 receptor type I p n n n n n n n p n CD247 T-cell receptor z-chain , CD3z p p CD16 CD16a, FcgRIIIa S / Act n p p p n n p l CD121b IL-1 receptor type II n p S p n n n S CD248 TEM1, Endosialin, CD164L1 p CD16b FcgRIIIb p n n l CD122 IL-2Rb p p n p p n n n l CD249 Aminopeptidase A p CD17 LacCer, lactosylceramide p S p n p p n Tons p p CD123 IL-3Ra n S p p p p p l CD252 OX40L, CD134L, TXGP1, TNFSF4 p p p CD18 b2 integrin chain p p p p p p n p n l CD124 IL-4Ra Act Act n n p n n p n n p CD253 TRAIL, APO2L, TNFSF10 Act p p p CD19 B4 , Bgp95 n p n n n n n p Folli n n l CD125 IL-5Ra n S S n n n n n CD254 TRANCE, TNFSF11, RANKL Act CD20 B1, Bgp35 Low p n n n n n n Folli n n l CD126 IL-6Ra p p n n p n l CD255 TWEAK, APO3L, DR3-L, TNFSF12 p p p p CD21 CR2, EBV-R, C3d-receptor, gp140 S p n n n n n p Folli n Low l CD127 IL-7Ra p n n p n n p n l CD256 APRIL, TNFSF13, TALL2 p CD22 BL-CAM, Siglec2, Bgp135 n p n n n n n p n n n l CD128a IL-8Ra, CXCR1-> Reassigned CD181 see CD181 CD257 BLyS , BAFF, TALL1 , TNFSF13B p p CD23 FceRII, Blast-2, low affinity IgE receptor, IGEBF, gp50-45 p Act p n p p n Folli n p l CD128b IL-8Rb, CXCR2 -> Reassigned CD182 see CD182 CD258 LIGHT, TNFSF14 S CD24 BA-1, HSA (Heat stable antigen homologue) n p p n n n n n n n p l CD129 IL-9Ra p p CD261 TRAIL-R1, DR4, TNFRSF10A CD25 IL-2Ra, Tac antigen S / Act Act n p p n n n n n n l CD130 gp130 Low Act Low Low p n p n p CD262 TRAIL-R2, DR5, TNFRSF10B CD26 DPPIV ectoenzyme, ADA-binding protein, Tp103 p p n p p n n n n n p l CD131 common b-chain n n p n p p CD263 TRAIL-R3, DcR1, TNFRSF10C p p p p p CD27 T14, S152, Tp55, TNFRSF7 p Act n p n n n n n n n l CD132 common g-chain, IL-2Rg p p p p p n CD264 TRAIL-R4, DcR2, TNFRSF10D, TRUNDD p p p p p n CD28 Tp44 S n n n n n n n n n n l CD133 PROML1 (prominin-like 1) n n n n n n n p n p p CD265 TRANCE-R, RANK, TNFRSF11A, EOF, FEO, OFE, ODFR, PDB2 p p p p p n n p CD29 platelet GPIIa, VLA-bchain, Integrin b1 chain p p Low p p p p p p p l CD134 OX40, TNFRSF4 Act n n l CD266 TWEAK-R, TNFRSF12A, FN14 p CD30 Ki-1 antigen, Ber-H2 antigen, TNFRSF8 Act Act n Act p n n p p n l CD135 FLT3, STK-1 n n n n n n n p n l CD267 TACI, TNFRSF13B p CD31 PECAM-1, platelet GPIIa’, endocam S S p p p p n p l CD136 RON, MSP-R ( stimulating protein receptor) p p l CD268 BAFFR, BR3 p p p p p n CD32 FCgRII, FCGR2A, gp40 S / Low p p n p p n n l CD137 4-1BB, ILA (induced by lymphocyte activation), TNFRSF9 Act Act n n p Folli p CD269 BCMA, BCM, TNFRSF17 CD32b FCGR2B, IGFR2 S p p n p p n p CD138 Syndecan-1, n p n n n n n p p p l CD270 TNFRSF14, TR2, ATAR, HVEA, HVEM, LIGHTR p p S CD32c FCGR2C, IGFR2 p p p CD139 - n p p n p Low n Folli CD271 NGFR (p75), LNGFR, NTR, TNFRSF16 Folli CD33 My9, gp67, p67, Siglec3 S / Act n Low n p n n p p n n l CD140a PDGF Ra (platelet-derived receptor a) n n n n n p n p CD272 BTLA (B and T lymphocyte attenuator) p p n p S CD34 gp105-120, My10 n n n n n n n p n p l CD140b PDGF Rb (platelet-derived b) n n n n n n n p CD273 PD-L2, B7-DC, PDCD1LG2 Act Act CD35 CR1, /C4b receptor, Receptor S p p S S n p Folli l CD141 TM (), fetomodulin, BDCA-3 n n p n p p n p p l CD274 B7-H1, PD-, PDCD1LG1 p p p p p p l CD36 platelet GPIV, GPIIIb, OKM5-antigen, PASIV n n n n p p p p p p n l CD142 , thromboplastin, coagulation factor III n n n n p n p p CD275 B7-H2, B7RP-1, ICOS-L, GL50 p p p n p p CD37 gp52-40, Tspan-26 Low p Low n Low n n l CD143 ACE (angiotensin-converting ), peptidyl dipeptidase A S n n n Act n n p p CD276 B7-H3 Act Act Act Act Act CD38 T10, gp45, ADP-ribosyl cyclase Act p n p p p p l CD144 VE-, cadherin-5 n n n n n n n n p n l CD277 BT3.1, BTF5 p p p p p p CD39 gp80, E-ATPDase, NTPDase-1 S / Act Act p p n p p p l CDw145 - n n n n n p p CD278 ICOS (inducible costimulator) Act l CD40 Bp50, TNF receptor 5 S p n n p n S Folli p S l CD146 MUC18, S-Endo, MCAM, Mel-CAM, A32 S / Act n n n n n n Folli p l CD279 PD1, PDC1 Act Act Act l CD41 platelet GPIIb, aIIb integrin, HPA3 n n n n n p n p n n n l CD147 EMMPRIN (extracellular metalloprotein inducer), M6, p p p p p p p p CD280 Endo180, TEM22, MRC2 p p p CD42a platelet GPIX, gp9 n n n n n p n p n n n l CD148 HPTP-h, DEP-1, p260 p p p p p p p n CD281 TLR1 (TOLL-like receptor 1), TIL p p CD42b platelet GPIb-a, Glycocalicin n n n n n p n p n n n l CD149 Now CD47R Now CD47R CD282 TLR2 (TOLL-like receptor 2), TIL4 p p CD42c platelet GPIb-b n n n n n p n p n n n CD150 SLAM (signaling lymphocyte activation molecule), IPO-3 S S n n n n n p p CD283 TLR3 (TOLL-like receptor 3) p p n n n p CD42d platelet GPV n n n n n p n p n n n CD151 PETA-3 (platelet-endothelial tetra-span antigen), SFA-1, Tspan-24 n n n n p p n p p CD284 TLR4 (TOLL-like receptor 4) p CD43 leukosialin, sialophorin, gpL115, gp95 p Act p p S Low n p l CD152 CTLA-4 (cytotoxic T lymphocyte antigen) S / Act S / Act n n n n n l CD285 TLR5 (TOLL-like receptor 5), TIL3 p S CD44 Pgp-1; gp80-95, Hermes antigen, ECMR-III, HUTCH-I, H-CAM p p p p p n p p p l CD153 CD30 , CD30L Act p Act n CD286 TLR6 (TOLL-like receptor 6) p p p CD44R CD44v1-10, CD44 variant Act Act Act p p CD154 CD40 ligand, CD40L, gp39, TRAP, T-BAM Act Act p Act n p n l CD287 TLR7 (TOLL-like receptor 7) p S CD45 LCA, T200, B220, EC 3.1.3.4 p p p p p n n p p n n l CD155 PVR (polio virus receptor), nectin-like 5 p n n CD288 TLR8 (TOLL-like receptor 8) p p p CD45RA restricted T200 S p n p p n n p p n n l CD156a ADAM8, MS2 p p CD289 TLR9 (TOLL-like receptor 9) p p p n p Plasm CD45RB restricted T200 S p Low p p n n p p n n CD156b ADAM17, TACE, snake venom like protease CSVP p n p n p n n n n p n CD290 TLR10 (TOLL-like receptor 10) p p p p CD45RC restricted T200 S p n p p n n p p n n CD156c ADAM10 p p p CD291 TLR11 (TOLL-like receptor 11) CD45RO restricted T200 S p p p p n n p p n n l CD157 BST-1, Mo5 S S p p p Folli p l CD292 BMPR1A, ALK-3 p CD46 MCP (membrane protein) p p p p p p n p p CD158a KIR2DL1, p58.1 S S l CDw293 BMPR1B, ALK-6 p CD47 IAP, Rh-associated protein, OA3, gp42, MEM-133, CDw149 p p p p p p p p p CD158b1 KIR2DL2, p58.2 S S l CD294 CRTH2, GPR44, PGRD2, DP2 S p l CD48 Blast-1, HuLym3, p p n p p n n p l CD158b2 KIR2DL3, p58.3 S S l CD295 LEPR (), OBR, B219 p p p p p p p p p p CD49a integrin a1, VLA-1 achain Act n n p p n n p n CD158c KIR2DS6, KIRX, KIR3DP1 S S CD296 ART1 S p CD49b integrin a2, VLA-2 achain, platelet gpIa Act p n p p p n p p p l CD158d KIR2DL4, KIR103AS S S CD297 ART4, Dombrock blood group Act p Low CD49c integrin a3, VLA-3 achain p p n p n p p CD158e1 KIR3DL1, p70, NKBI S S l CD298 Na/K-ATPase b3 subunit p p p p p p p p CD49d integrin a4, VLA-4 achain p p n p p n n p p p l CD158e2 KIR3DS1, p70 S S l CD299 DC-SIGN-2, DC-SIGNR, L-SIGN S CD49e integrin a5, VLA-5 achain p Act p p p p p p p p l CD158f KIR2DL5 S S l CD300a IRP60, CMRF35H9, IRC1, IRC2 S S S S S p l CD49f integrin a6, VLA-6 achain, platelet gpIc p p p p p p CD158g KIR2DS5 S S CD300c LIR, CMRF35A1 S S p p p CD50 ICAM-3 (intercellular adhesion molecule 3) p p p p p n n p p n l CD158h KIR2DS1, p50.1 S S l CD300e CMRF35L1 p p CD51 integrin av, VNR achain S n Act Low p CD158i KIR2DS4, p50.3 S S l CD301 MGL, CLECSF14, CLEC10A, HMGL p S CD52 Campath-1, HE5 p p p p n n S p l CD158j KIR2DS2, p50.2 S S l CD302 DCL1, BIMLEC, CLEC13A p p p CD53 MEM-53, tetraspanin-25, Tspan-25 p p p p p n n p p n CD158k KIR3DL2, p140 S S CD303 BDCA2, CLECSF11, DLEC, HECL Plasm CD54 ICAM-1 (intercellular adhesion molecule 1) Act Act Low Low Low l CD158z KIR3DL3, KIR3DL7, KIRC1, KIR44 S CD304 BDCA-4, -1, VEGF165R S Plasm CD55 DAF (Decay accelerating factor) p p p Low p p p p p p l CD159a NKG2A, KLRC1 S l CD305 LAIR1 (leucocyte-associated Ig-like receptor 1) p p p p p p CD56 NCAM (neural ), NKH1 S p l CD159c NKG2C, KLRC2 p CD306 LAIR-2 (leucocyte-associated Ig-like receptor 2) p p p CD57 HNK1 S / Act S l CD160 BY55, NK1, NK28 p n p l CD307 IRTA2, FcRH5, BXMAS1 S CD58 LFA-3 (lymphocyte function associated antigen-3) p p p p p p p p p l CD161 NKR-P1A p n n p n n n n n l CD307a FCRL1, FCRH1, IFGP1, IRTA5 n p n n n n CD59 MACIF, MIRL, P-18, HRF20, 1F-5Ag, H19, protectin p p p p p l CD162 PSGL-1 p p p p n n p n CD307b FCRL2, FcRH2, IFGP4, IRTA4, SPAP1 n p n n n n CD60a GD3 S Low p p p n CD162R PEN5, PSGL1, SELPLG ( P ligand) p CD307c FCRL3, FcRH3, IFGP3, IRTA3, SPAP2 p p n n n n CD60b 9-O-acetyl-GD3 S Act CD163 M130 n n n p n n n n n CD307d FCRL4, FcRH4, IFGP2, IRTA1 n p n n n n CD60c 7-O-acetyl-GD3 S CD164 MGC-24, MUC-24 Low Low n p n p p p CD307e FCRL5 n p n n n n n CD61 GPIIIa, b3 integrin p p p l CD165 AD2, gp37 S / Low n p p n n p CD307f FCRL6 p CD62E E-selectin, ELAM-1, LECAM-2 Act CD166 ALCAM, KG-CAM Act n Act p p p l CD308 VEGFR1 (vascular endothelial growth factor receptor 1), Flt-1 p p CD62L L-selectin, LAM-1, LECAM-1 p p p S p l CD167a DDR1, trkE, trk6, RTK6, NTRK4, MCK10, cak, eddr1 Low p p CD309 VEGFR2 (vascular endothelial growth factor receptor 2), KDR p p l CD62P P-selectin, GMP140, PADGEM Act Act l CD167b DDR2, TKT, MIG20a, NTRKR3, TYRO10 CD310 VEGFR3 (vascular endothelial growth factor receptor 3), Flt-4 p CD63 LIMP, gp-55, Pltgp40, LAMP-3, granulophysin p S / Low Low p p Act n Act l CD168 RHAMM (receptor for hyaluronan involved in migration and motility) S / Act Act p Low CD311 EMR1 p CD64 FcgRI Act S l CD169 SN (), Siglec-1 p p CD312 EMR2 Act p p p CD64a FCRI, IGFR1 n n p n p n n p p n n CD170 Siglec-5 n p n S p CD313 EMR3 p p CD65 Ceramide-dodecasaccharide 4c n n p p l CD171 N-CAM (neural cell adheion molecule), L1 S S p p p CD314 NKG2D p p p n l CD65s VIM2, sialylated-CD65 n n p n p n n n CD172a SIRPa (signal regulatory protein a), SHPS-1 p p CD315 CD9P1, SMAP6, FPRP S Act CD66a BGP, NCA-160 Act n p p n n n p CD172b SIRPb1 (signal regulatory protein b1) p p CD316 EWI-2, IgSF8, PGRL p p p CD66b CGM6, NCA-95, previously CD67 n n p n n n n l CD172g SIRPb2 (signal regulatory protein b2), SIRPg, p p CD317 BST2 (bone marrow stromal cell antigen 2), HM1.24 p p p p p CD66c NCA, NCA50/90, KOR-SA3544 n n p n n n n p l CD173 blood group H2 n p p p CD318 CDCP-1 (CUB domain-containing protein 1), SIMA135 p CD66d CGM1 n n p n n n n CD174 Lewis Y blood group n S CD319 CRACC, SLAMF7 S Act p S CD66e CEA () n n n n n n p CD175 Tn antigen p p n S p CD320 8D6A Folli CD66f PSG (pregnancy-specific glycoprotein), Sp-1 n n n n n n p CD175s Sialyl-Tn n p n p p p CD321 JAM-1 (junctional adhesion molecule-1), JAM-A, F-11R p p p p p p CD68 gp110 Act p p p n n S p CD176 TF (Thomsen-Friedenreich antigen) n p S p p CD322 JAM-2 S p p p CD69 AIM (activation-induced molecule), MLR3, EA1 Act p p p p p l CD177 NB1, PRV1 (polycythemia vera rubra 1), HNA-2a S CD323 JAM-3, JAM-C, VE-JAM p p p p CD70 CD27 ligand, KI-24 antigen Act Act n Act n n n n n n n CD178 , TNFSF6, APT1LG1, CD95L Act n p p n n n p p CD324 E-Cadherin, cadherin 1, ECAD, CDHE, CDH1, uvomorulin p p p CD71 T9, receptor n n n n p n p l CD179a Vpre-b, VPREB1 (pre lymphocyte gene 1), IGVPB CD325 N-Cadherin, Cadherin 2, NCAD, CDHM, CDH2 p p CD72 Ly-19.2, Ly32.2 p n n p n n p Folli CD179b Ig Lambda 5, IGLL1 CD326 Ep-CAM, EGP40 p CD73 Ecto-5'-nucleotidase S S n n n n n p Folli p p CD180 RP105, Bgp95 S p p l CD327 siglec6, OB-BP1, CD33L p Low CD74 MHC class II invariant chain, class II specific chaperone Act p p p Act Act CD181 CXCR1, IL-8Ra, formerly CD128a S p Low p CD328 AIRM1, , p75 S Low p p l CD75 lactosamines S S n n p n p n n S CD182 CXCR2, IL-8Rb, formerly CD128b S p Low p CD329 S S p p p CD75s sialylated lactosamines S S p n p n p n S S CD183 CXCR3, GPR9 (G protein-coupled receptor 9) Act p Act p CD330 S S p S p CD77 Gb3, BLA, CTH, Pk blood group antigen n p n n n n n n p p l CD184 CXCR4, fusin, LESTR, NPY3R S p p p p p p l CD331 FGFR1 ( receptor 1), FLT2, FLG p p CD79a mb-1 gene product, IGA, Ig-a n p n n n n n n n n l CD185 CXCR5, BLR1, MDR15 p p p p p p CD332 FGFR2, KGFR (keratinocyte growth factor receptor), TK14, BEK p CD79b B29 gene product, IGB, Ig-b n p n n n n n n n n l CD186 CXCR6, BONZO, STRL13 Act CD333 FGFR3, JTK4 p CD80 BB1, B7-1 Act Act n n p n n n p n n l CD191 CCR1, CKR1 p p p S CD334 FGFR4, JTK2, TKF p CD81 TAPA-1, M38 p p Low p p n n p p p p l CD192 CCR2, CKR2, MCP-1-R Act p p p p CD335 NKp46, NCR1 p l CD82 R2, IA4, 4F9, C33 Low Low p p p p n p p p CD193 CCR3, CKR3, Eosinophil eotaxin receptor p S / Low p p CD336 NKp44, NCR2 S Act l CD83 HB15 Act Act n n n n n n p n n l CD194 CCR4 S S p p CD337 NKp30, NCR3 p l CD84 p75, GR6, SLAMF5 S p n p S p n n p n n CD195 CCR5, CKR5 S n n p n n n CD338 ABCG2, BCRP1 S S CD85a ILT5/LIR3, HL9 S n p Low p n n p Low n n CD196 CCR6, CKR6, LARC receptor S p n S n S l CD339 Jagged-1, JAG1 p CD85b ILT8, LILRB6 S p S p p CD197 CCR7, EBI1, BLR2 S Act S l CD340 HER2/neu, ERBB2 S p CD85c LIR8 p p CDw198 CCR8, CKRL1, GPRCY6, TER1 S p CD344 Fz4, -4 p p CD85d ILT4/LIR2, MIR10 Low S l CDw199 CCR9, CMKBR9, D6, GPR-9-6 S CD349 Fz-9, Frizzled-9 p CD85e ILT6/LIR4, HM31, HM43 p p p p CD200 OX2, MRC Act Low n n n n n p Folli p l CD350 Fz10, Frizzled-10 p CD85f ILT11 p CD201 EPC R, CCCA, CCD41, bA42O4.2 p S CD351 FCA/MR, , IgA, IgM, high affinity p p n n p Folli CD85g ILT7 p p p CD202b TIE2, TEK S p p CD352 SLAMF6, NTB-A, KAL1, Ly108 p p S p p l CD85h ILT1/LIR7 CD203c E-NPP3, NPP3, PDNP3, B10, PD-1b S l CD353 SLAMF8, BLAME, SBBI42 Act Act n n Act S CD85i LIR6a, LILRA1 p p CD204 MSR (macrophage scavenger receptor), SRA p CD354 TREM1 (Triggering receptor expressed on myeloid 1) p p S CD85j ILT2/LIR1, MIR7, LILRB1 S Low S p p l CD205 DEC205, CLEC13B, gp200-MR6, Ly75 p p p p p CD355 CRTAM (Cytotoxic and regulatory T-cell molecule) p p p n n CD85k ILT3/LIR5, HM18 p p l CD206 MMR (macrophage receptor) p S p p l CD356 TNFRSF14, HVEM, HVEA, ATAR, TR2 S CD85l ILT9 CD207 , Lag p l CD357 TNFRSF18, GITR, AITR S / Act n p CD85m ILT10, LILRA5, LILRP2 CD208 DC-LAMP ACT l CD358 TNFRSF21, DR6 p p n n p n CD86 B7.2, B70 n S n n p n n n p p n l CD209 DC-SIGN p p p l CD359 IL15RA p n n n n CD87 uPAR (urokinase plasminogen activator receptor) S / Act n Low p p n n n S p n CD210a IL-10RA, IL10R1, CRFB4 p p n n p n CD360 IL21R, NILR p p p p p p CD88 C5a-R (complement 5a receptor) n n p n p n n n p p p CDw210b IL-10RB, IL10R2, CRFB4 p p p p p CD361 EV12B (Ecotropic viral integration site 2B) p p p p p n CD89 FcaR, IgA receptor, IgA Fc receptor n n p n p n n p n n CD212 IL-12 receptor b1-chain p p n p n n CD362 Syndecan-2, SDC2, HFGP1 p p p n p n CD90 Thy-1 S n n n n n n p Act n l CD213a1 IL-13 receptor a1, NR4 p p p p CD363 S1PR1, EDG-1, CHEDG1 p p n p n n CD91 a2M-R, LRP, LDL receptor n n n n p n n n p CD213a2 IL-13 receptor a2 p p p CD365 TIM-1, HAVCR1, TIMD1 S / Act S p CD92 VIM15, p70, CHTL1 Low Low p n p n n Low Low CD215 IL-15RA p p n n n n CD366 TIM-3, HAVCR2, TIMD3 S CD93 C1qR1, GR11, C1qRP n n p p n n n p n CD217 IL-17 receptor p p p p p p p p p CD367 DCIR, CLECSF6, CLEC4A, DDB27 p S p p CD94 Kp43 S n n p n n n n n l CD218a IL-18 receptor a p p p p p p CD368 CLEC6, MCL, CLECSF8, CLEC4D p S S CD95 Fas, APO-1, TNFRSF6, APT1 S S p S p n n l CD218b IL-18 receptor b p p p p p CD369 DECTIN-1, CLEC7A, CLECSF12 S p p CD96 TACTILE Act Low n Act n n n CD220 receptor, INSR p p p p p p p p p CD370 DNGR1, CLEC9A, HEEE9341, UNQ9341 S l CD97 BL-KDD/F12 Act Act p p p n n p CD221 IGF1 receptor p p p p p p p p p CD371 CLL-1, MICL, CLEC12A, DCAL-2 p p p CD98 4F2, FRP-1 p p p p p p n p p CD222 man-6p, IGF2R, CIMPR, M6P-R p p p p p p p p p

References: • Leucocyte Typing: Bernard, A., et al. Eds., Springer-Verlag (1984) Content reflects information analyzed from the referenced publications. Codes: I Paris - France 1982 VI Kobe - Japan 1996 • Leucocyte Typing II: Reinherz,E.L., et al. Eds., Springer-Verlag (1986) : negative S : positive on a subset : positive • PROW web site: http://www.ncbi.nlm.nih.gov/prow/ • Leucocyte Typing III: McMichael, A.J., et al. Eds., Oxford University Press (1987) II Boston - USA 1984 VII Harrogate - UK 2000 • HCDM web site: http://www.hcdm.org • Leucocyte Typing IV: Knapp, W., et al. Eds., Oxford University Press (1989) III Oxford - UK 1987 VIII Adelaide - Australia 2004 Act : positive upon activation S/Low : low expression on a subset : no data • Leukocyte and Stromal Cell Molecules, The CD Markers, Zola, H., et al. Eds. Wiley-Liss • Leucocyte Typing V: Schlossman, S.F., et al. Eds., Oxford University Press (1995) IV Vienna - Austria 1989 IX Barcelona - Spain 2010 S/Act : subset of activated cells l : clone available at Beckman Coulter (2007) Low : low expression • Leucocyte Typing VI: Kishimoto, T., et al. Eds., Oxford University Press (1997) V Boston - USA 1993 X Wollongong - Australia 2014 Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered in the USPTO. • Leucocyte Typing VII: Mason, D., et al. Eds., Oxford University Press (2002) FLOW-872PST11.15-A © 2015 Beckman Coulter, Inc.